Personal Finance
Putting Capital to Work – Pfizer Investor Insights
In 2022, Pfizer has put capital to work as we strive to fuel future growth and return cash dividends directly to investors. In the first six months of 2022, the company re-invested more than $12 billion in total into innovation, consisting of $5.1 billion in its R&D innovation pipeline and more than $7 billion in […]
Read the full article here